Last updated: Nov 20, 2026, 12:00 AM

Contineum Therapeutics, Inc. Class A Common Stock Exchange (NASDAQ, USD)

CTNM

8.68
-0.20 (-2.16%)
HealthcareBiotechnology
Invest Today
Invest Today
1 year return (CAGR)
-21.46%
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Stock Analysis

Adobe 2026 Q3 – Is sentiment driving the price?

Read More
Marketcap
297.95M
Price/Sales
-
Ent value
293.94M
Price/Book
1.24
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-

Stock information

iO Charts Blog

What is a stock exchange? Operation, actors, examples

Read More

Stock chart

Loading...
Stock price data
Open9.31
Daily high9.63
Daily low8.93
Daily Volume190K
All-time high21.75
1y analyst estimate22.14
Beta1.07
EPS (TTM)-1.54
Dividend per share0.00
Ex-div date-
Next earnings date5 Mar 2026

Ready to capitalize on Contineum Therapeutics, Inc. Class A Common Stock's growth potential?

Take the next step in your portfolio.

Invest Today

Downside potential

Loading...
Downside potential data
CTNMS&P500
Current price drop from All-time high-60.09%-11.46%
Highest price drop-84.37%-56.47%
Date of highest drop28 May 20259 Mar 2009
Avg drop from high-40.84%-10.64%
Avg time to new high37 days12 days
Max time to new high591 days1805 days